Terms: = Cervical cancer AND PR, PGR, progesterone receptor AND Prognosis
73 results:
1. Socioeconomic status and cancer survival in Brazil: Analysis of population data from the municipalities of Aracaju and Curitiba, 1996-2012.
Renna Junior NL; Azevedo E Silva G
Cancer Epidemiol; 2023 Aug; 85():102394. PubMed ID: 37419053
[TBL] [Abstract] [Full Text] [Related]
2. The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.
Zhang CY; Zhang L; Wang ZM; Ren DH; Zheng HC
J Obstet Gynaecol; 2023 Dec; 43(1):2213764. PubMed ID: 37218920
[TBL] [Abstract] [Full Text] [Related]
3. Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive cancers: Breast cancer, cervical cancer, Endometrial cancer, Ovarian cancer and Prostate cancer.
Korbecki J; Bosiacki M; Barczak K; Łagocka R; Brodowska A; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108425
[TBL] [Abstract] [Full Text] [Related]
4. Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma.
Lian CL; Zhou R; Zhou Y; Zhou P; Wu SG
Drug Des Devel Ther; 2023; 17():551-562. PubMed ID: 36855516
[TBL] [Abstract] [Full Text] [Related]
5. Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.
Hu Y; Han Y; Shen Y; Chen J; Chen Y; Chen Y; Tang J; Xue M; Hong L; Cheng W; Wang D; Liang Z; Wang Y; Zhang Q; Xing H; Zhang Y; Yi C; Yu Z; Chen Y; Cui M; Ma C; Yang H; Li R; Long P; Zhao Y; Qu P; Tao G; Yang L; Wu S; Liu Z; Yang P; Lv W; Xie X; Ma D; Wang H; Li K
BMC Cancer; 2022 Dec; 22(1):1270. PubMed ID: 36471257
[TBL] [Abstract] [Full Text] [Related]
6. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
7. The contribution of the
Dolciami M; Canese R; Testa C; Pernazza A; Santangelo G; Palaia I; Rocca CD; Catalano C; Manganaro L
Eur Radiol Exp; 2022 Oct; 6(1):47. PubMed ID: 36184731
[TBL] [Abstract] [Full Text] [Related]
8. Effect of immunotherapy on the immune microenvironment in advanced recurrent cervical cancer.
Chen R; Yang W; Li Y; Cheng X; Nie Y; Liu D; Wang H
Int Immunopharmacol; 2022 May; 106():108630. PubMed ID: 35189471
[TBL] [Abstract] [Full Text] [Related]
9. Post-recurrence survival in patients with cervical cancer.
Cibula D; Dostálek L; Jarkovsky J; Mom CH; Lopez A; Falconer H; Scambia G; Ayhan A; Kim SH; Isla Ortiz D; Klat J; Obermair A; Di Martino G; Pareja R; Manchanda R; Kosťun J; Dos Reis R; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Benešová K; Borčinová M; Cardenas F; Wallin E; Pedone Anchora L; Akilli H; Abu-Rustum NR; Barquet-Muñoz SA; Javůrková V; Fischerová D; van Lonkhuijzen LRCW
Gynecol Oncol; 2022 Feb; 164(2):362-369. PubMed ID: 34955236
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathological features of malignant mixed mesodermal tumor: analysis of 50 cases].
Ding XH; Ma ZY; Wang YF; Dou FX; Yuan J; Tian X; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1008-1013. PubMed ID: 34496490
[No Abstract] [Full Text] [Related]
11. APLN: A potential novel biomarker for cervical cancer.
Chen Y; Lin X; Zheng J; Chen J; Xue H; Zheng X
Sci Prog; 2021; 104(2):368504211011341. PubMed ID: 33881940
[TBL] [Abstract] [Full Text] [Related]
12. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
[TBL] [Abstract] [Full Text] [Related]
13. progesterone receptor Is a Haploinsufficient Tumor-Suppressor Gene in cervical cancer.
Park Y; Baik S; Ho C; Lin CY; Chung SH
Mol Cancer Res; 2021 Jan; 19(1):42-47. PubMed ID: 33139507
[TBL] [Abstract] [Full Text] [Related]
14. Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer.
Tian X; Ge D; Zhang F; Zhang B; Bai W; Xu X; Li Z; Cao Y; Li P; Zou K; Zou L
Int J Cancer; 2021 Feb; 148(4):921-931. PubMed ID: 33113150
[TBL] [Abstract] [Full Text] [Related]
15. Pulmonary recurrence after radical hysterectomy for uterine cervical carcinoma.
Kilic C; Yuksel D; Cakir C; Karalok A; Boyraz G; Moraloglu Tekin O; Turan T
J Obstet Gynaecol; 2020 Nov; 40(8):1155-1159. PubMed ID: 32027187
[TBL] [Abstract] [Full Text] [Related]
16. Advanced uterine adenosarcoma with sarcomatous overgrowth in a young woman: A case report.
Wang B; Yang HD; Shi XH; Li H
Medicine (Baltimore); 2019 Nov; 98(47):e18119. PubMed ID: 31764852
[TBL] [Abstract] [Full Text] [Related]
17. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
[No Abstract] [Full Text] [Related]
18. Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix.
Zhu R; Wu H; Chen B; Pang J; Huo Z
Diagn Pathol; 2019 Jun; 14(1):64. PubMed ID: 31228945
[TBL] [Abstract] [Full Text] [Related]
19. Role of pgrMC1 in cell physiology of cervical cancer.
Shih CC; Chou HC; Chen YJ; Kuo WH; Chan CH; Lin YC; Liao EC; Chang SJ; Chan HL
Life Sci; 2019 Aug; 231():116541. PubMed ID: 31216441
[TBL] [Abstract] [Full Text] [Related]
20. High expression of survivin predicts poor prognosis in cervical squamous cell carcinoma treated with paclitaxel and carboplatin.
Zhang Y; Yan H; Li R; Guo Y; Zheng R
Medicine (Baltimore); 2019 May; 98(20):e15607. PubMed ID: 31096466
[TBL] [Abstract] [Full Text] [Related]
[Next]
